Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.400 |
None |
1.000 |
2 |
1
|
2011 |
2019 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.110 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
6 |
5
|
2017 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
4 |
6
|
2016 |
2019 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
3 |
4
|
2016 |
2019 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
3 |
4
|
2016 |
2018 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
478
|
667
|
0.100 |
None |
1.000 |
2 |
1
|
2011 |
2015 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.100 |
None |
1.000 |
2 |
1
|
2014 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2019 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.100 |
None |
1.000 |
1 |
3
|
2018 |
2018 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
578
|
1158
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Interleukin 10 Measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
24
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Interleukin 2 Measurement
|
phenotype |
|
Laboratory Procedure
|
5
|
6
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Interferon Gamma Measurement
|
phenotype |
|
Laboratory Procedure
|
5
|
10
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Interleukin 1 Beta Measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
149
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Soluble Interleukin 6 Receptor Measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
25
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Mood Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
580
|
308
|
0.100 |
None |
1.000 |
1 |
3
|
2018 |
2018 |
Biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
132
|
36
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Protein measurement
|
group |
|
Laboratory Procedure
|
75
|
422
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Psoriasis vulgaris
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
255
|
80
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |